From Longevity Theory to Clinical Practice
Dr. Harry F. König, M.D. — Longevity & Integrative Medicine Specialist
Dr. Harry F. König, M.D., is a longevity and integrative medicine specialist with decades of clinical experience. His work bridges clinical practice, preventive health, regenerative medicine, and evidence-informed longevity protocols.
This lecture translates contemporary longevity science into structured clinical reality. It demonstrates how evolving theories in preventive medicine, metabolic optimization, regenerative therapies, and advanced diagnostics are systematically integrated within a modern longevity practice and the Monade Private Longevity Sanctuary. Emphasis is placed on measurable outcomes, individualized risk stratification, and sustainable implementation models that enhance metabolic resilience, cognitive performance, and long-term vitality. The presentation provides a practical framework for physicians and health leaders seeking to transform scientific insight into reproducible, patient-centered healthspan results.
Longevity is not only biohacking and collecting information; it is a strategic decision for your life. Guidance is the bridge from biohacking into real life, into your individual longevity.
Summary
- Longevity should be a personalized life strategy based on an individual's unique genetics and history rather than a collection of trendy biohacking tools. - The "Glucose Adapted Diet" levels blood sugar by avoiding snacking and never starting a meal with carbohydrates to prevent insulin spikes and maintain energy. - Comprehensive diagnostics covering biochemistry, physical condition, and mental health are the necessary backbone for creating an effective, data-driven personal health roadmap. - Specialized clinical treatments can address chronic fatigue and weakness by removing environmental toxins, heavy metals, and reactivated viruses from the blood. - A tiered approach ensures health interventions prioritize lifestyle foundations and diagnostics before moving to individual supplementation or complex medical procedures.
Article
From Longevity Theory To Clinical Practice
Dr. Harry F. König At Hololife Longevity Cote D'Azur
At Hololife Longevity Cote d'Azur in Nice, France, on Thursday, 12 March 2026, Dr. Harry F. König, M.D., offered a brisk but deeply revealing argument for what modern longevity medicine ought to become. His presentation, *From Longevity Theory to Clinical Practice: Strategic & Individualized Integrative Medicine*, pushed back against the glossy reduction of long life into gadgets, drips and fashionable self-optimization. In its place, he proposed something both more demanding and more humane: longevity as a disciplined, individualized life strategy.
For Dr. König, a longevity and integrative medicine specialist with decades of clinical experience, the question was never whether biohacking had value. It was whether any intervention, however advanced, meant much without first understanding the whole person. That, he suggested, was the difference between trend and treatment, between fragmented medicine and actual care.
The Case Against Fragmented Health
The central force of the talk lay in its refusal to romanticize specialization. Dr. König described the limits of a system in which patients move from one expert to another, each treating a body part, few treating a life.
“Understanding the person in front of you is the key to helping them,” he said. “It is the key to a strategy that ensures you are taken care of for the next decades of your life.”
That line captured the moral center of the presentation. Longevity, in his view, was not a retail experience built from supplements and diagnostics bought à la carte. It was a relationship, ideally guided by a clinician capable of seeing patterns across family history, emotional stress, physical decline, laboratory data and daily habits.
He argued that generalist, integrative care remained essential precisely because a person’s health story rarely fit neatly inside a single specialty. A divorce, bereavement, financial instability, chronic fatigue, poor sleep, post-viral weakness, metabolic dysfunction: these were not isolated events, but overlapping pressures. If medicine ignored the links, it missed the patient.
Salutogenesis As A Starting Point
Dr. König rooted this philosophy in salutogenesis, the principle that medicine should not merely manage disease but actively cultivate health. In practice, he described this as a process of truly knowing the patient, not simply their lab values.
That meant broad intake conversations, physical examination, and diagnostics spanning biochemistry, vascular health, hormonal status, posture, scars, mental state and, when relevant, genetics and epigenetics. The point was not data accumulation for its own sake. It was strategy.
Longevity, he made clear, should begin with a map.
The body’s chemistry, physical condition and psychological balance formed what he called the backbone of any credible plan. Only after that groundwork, he argued, should clinicians decide whether a patient needed simple lifestyle changes, targeted supplementation, or more complex clinical intervention.
The Simplicity And Severity Of Food
Some of the sharpest practical advice in the session concerned food. Dr. König outlined what he called the Glucose Adapted Diet, or GLAD, a framework designed to stabilize blood sugar and reduce insulin spikes through deceptively simple rules.
The first was to never begin a meal with carbohydrates. Fiber-rich vegetables and similar foods should come first, he said, because they soften the glucose surge that follows. The second was more absolute: no snacking between meals.
This, he argued, was not a faddish restriction but a metabolic intervention. By avoiding constant glucose peaks and crashes, patients could improve energy, weight regulation, cholesterol markers and long-term metabolic resilience.
His point was not that bread or carbohydrates were inherently forbidden. Timing, sequence and pattern mattered more than panic. In a field often crowded with absolutist claims, that nuance felt notable.
Movement As A Longevity Imperative
Dr. König was equally unsparing about inactivity. He dismissed the popular fixation on a universal 10,000-step target as weakly grounded, but he was unequivocal on a broader truth: a body not trained would decline faster.
“Longevity is about keeping yourself active,” he said. “The simple truth is that if you don't train your body and your muscles, you will degenerate much faster.”
Movement, in his framework, was not cosmetic and not optional. It was a core biological requirement, inseparable from blood sugar regulation, vascular function, energy and independence. The emphasis was not on athletic performance, but on preserving capacity.
Epigenetics And The End Of Fatalism
One of the more hopeful threads in the talk came when Dr. König addressed genetics. The older model, he suggested, encouraged a quiet fatalism, the belief that inherited risk was immutable. Contemporary longevity medicine, by contrast, increasingly pointed to modulation rather than surrender.
“We used to believe genetics were fixed, but we now know we can influence them,” he said. “This is what epigenetics is all about, choosing the right nutrition and supplements to lower your individual risks.”
This was not presented as magic, nor as a promise of total control. Rather, it was an argument for precision. Supplements should not be handed out as wellness confetti. They should follow diagnostics, personal history and measurable need. What one patient required, another might not.
In that distinction, Dr. König sketched a broader philosophy: personalization was not luxury medicine. It was medicine done properly.
When Clinical Intervention Becomes Necessary
Only after laying out these fundamentals did the presentation turn to more advanced therapies. Dr. König described a tiered system in which complex procedures belonged at the end of a process, not the beginning.
Among the interventions discussed were chelation for heavy metals, plasma washing to remove toxins and inflammatory burden, ozone therapy, individualized intravenous support, and hematophoresis for chronic viral activation. He spoke in particular about patients weakened by reactivated viruses such as Epstein-Barr virus, CMV or post-Covid syndromes, where standard testing often showed little despite profound fatigue.
His description of hematophoresis was especially striking: a blood filtration process designed to reduce circulating activated pathogens and inflammatory burden. Yet even here, his message remained cautious. Such treatments, he stressed, should follow careful diagnostics and should never replace foundational work on lifestyle, metabolic stability and whole-person assessment.
It was a notable inversion of the luxury-wellness marketplace, where dramatic interventions are often sold first and justified later.
A Critique Of The Health Industry
If there was an adversary in the room, it was not technology but complacency, and perhaps also the incentives of modern healthcare itself. Dr. König did not hide his suspicion that industry often profited more from lifelong disease management than from genuine recovery.
“Industry is not always interested in getting you healthy; it would rather have a patient for a lifetime,” he said. “We want to help you reach your best personal health, not just control a problem.”
The remark landed because it echoed a broader unease, one familiar to many patients who feel expertly treated yet never truly restored. His answer was not anti-medicine. It was, if anything, more rigorous medicine: slower at the beginning, broader in scope, more demanding of context, and less willing to medicate around the edges of unresolved dysfunction.
The Urgency Of Starting Young
In the question-and-answer session, Dr. König was asked about blue zones and why some populations appeared to reach old age in good health without obvious intervention. His answer was unsentimental. Longevity, he suggested, was shaped not by romance but by conditions: education, awareness, climate, nutrition, stability and means.
That realism led to one of the talk’s most important appeals. Health strategy should begin early.
“Our responsibility is to broaden the vision of longevity to the youth,” he said. “We should start building health awareness when we are young, not just when we are already looking at the end of the horizon.”
This may have been the most consequential point of the day. Longevity was too often marketed as an elite response to midlife anxiety. Dr. König reframed it as an early, lifelong literacy, something built in one’s twenties, not purchased in crisis.
Beyond Biohacking
By the end of the session, the case he had made was clear. Longevity was not a stack of isolated interventions. It was a sequence. It began with awareness, deep diagnostics, disciplined eating, movement, psychological balance and regular reassessment. It then progressed, if necessary, toward individualized supplementation and advanced therapies.
The architecture mattered because order mattered. Start with the complex before understanding the simple, and both doctor and patient risked mistaking activity for care.
What Dr. Harry F. König offered at Hololife Longevity Cote d'Azur was not a miracle protocol. It was something rarer and, in its way, more radical: a demand that medicine see human beings whole. In a culture seduced by shortcuts, that sounded less like a trend than a correction.
Part of Hololife Longevity Cote d'Azur